EP0791012A1 - Peptides exhibiting oxytocin antagonistic activity - Google Patents

Peptides exhibiting oxytocin antagonistic activity

Info

Publication number
EP0791012A1
EP0791012A1 EP94921875A EP94921875A EP0791012A1 EP 0791012 A1 EP0791012 A1 EP 0791012A1 EP 94921875 A EP94921875 A EP 94921875A EP 94921875 A EP94921875 A EP 94921875A EP 0791012 A1 EP0791012 A1 EP 0791012A1
Authority
EP
European Patent Office
Prior art keywords
peptide
pharmaceutical composition
composition according
asn
nαmeorn
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP94921875A
Other languages
German (de)
English (en)
French (fr)
Inventor
Carl-Johan Aurell
Per Melin
Anders Nilsson
Jerzy Trojnar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ferring BV
Original Assignee
Ferring BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring BV filed Critical Ferring BV
Publication of EP0791012A1 publication Critical patent/EP0791012A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/16—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
EP94921875A 1993-07-13 1994-07-07 Peptides exhibiting oxytocin antagonistic activity Withdrawn EP0791012A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9302414A SE501678C2 (sv) 1993-07-13 1993-07-13 Peptid med oxytocinantagonistaktivitet samt farmaceutisk komposition innehållande nämnda peptid
SE9302414 1993-07-13
PCT/SE1994/000674 WO1995002609A1 (en) 1993-07-13 1994-07-07 Peptides exhibiting oxytocin antagonistic activity

Publications (1)

Publication Number Publication Date
EP0791012A1 true EP0791012A1 (en) 1997-08-27

Family

ID=20390606

Family Applications (1)

Application Number Title Priority Date Filing Date
EP94921875A Withdrawn EP0791012A1 (en) 1993-07-13 1994-07-07 Peptides exhibiting oxytocin antagonistic activity

Country Status (16)

Country Link
EP (1) EP0791012A1 (fi)
JP (1) JPH09502427A (fi)
KR (1) KR960702848A (fi)
CN (1) CN1126999A (fi)
AU (1) AU676071B2 (fi)
CA (1) CA2163114A1 (fi)
CZ (1) CZ9896A3 (fi)
FI (1) FI960119A (fi)
HU (1) HUT74874A (fi)
IL (1) IL110267A0 (fi)
NO (1) NO955059L (fi)
PL (1) PL312568A1 (fi)
SE (1) SE501678C2 (fi)
TW (1) TW268009B (fi)
WO (1) WO1995002609A1 (fi)
ZA (1) ZA945090B (fi)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9604341D0 (sv) 1996-11-26 1996-11-26 Ferring Bv Hepta-peptide oxytocin analogue
JP4615221B2 (ja) 2002-02-27 2011-01-19 フェリング ベスローテン フェンノートシャップ ヘプタペプチドオキシトシンアナログを製造するための中間体及び方法
CN108290929A (zh) * 2015-10-06 2018-07-17 辉凌公司 制造巴芦西班及其中间体的新型方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5373089A (en) * 1988-09-02 1994-12-13 Northwestern University Oxytocin antagonist
SE9002384D0 (sv) * 1990-07-09 1990-07-09 Ferring Ab Derivat av baklobshormoner
SE501677C2 (sv) * 1993-06-18 1995-04-10 Ferring Bv Biologiskt aktiva vasopressinanaloger, farmaceutiska preparat innehållande dem samt deras användning för framställning av läkemedel

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO9502609A1 *

Also Published As

Publication number Publication date
WO1995002609A1 (en) 1995-01-26
SE501678C2 (sv) 1995-04-10
CN1126999A (zh) 1996-07-17
CA2163114A1 (en) 1995-01-26
KR960702848A (ko) 1996-05-23
ZA945090B (en) 1995-02-22
TW268009B (fi) 1996-01-11
FI960119A0 (fi) 1996-01-10
SE9302414L (sv) 1995-01-14
AU7240694A (en) 1995-02-13
JPH09502427A (ja) 1997-03-11
NO955059D0 (no) 1995-12-13
CZ9896A3 (en) 1996-06-12
HU9503768D0 (en) 1996-02-28
AU676071B2 (en) 1997-02-27
SE9302414D0 (sv) 1993-07-13
HUT74874A (en) 1997-02-28
FI960119A (fi) 1996-01-10
IL110267A0 (en) 1994-10-21
NO955059L (no) 1995-12-13
PL312568A1 (en) 1996-04-29

Similar Documents

Publication Publication Date Title
US6143722A (en) Heptapeptide oxytocin analogues
FI92326C (fi) LHRH:n nonapeptidi- ja dekapeptidianalogeja, jotka ovat käyttökelpoisia LHRH:n antagonisteina
HU224345B1 (hu) Növekedési hormont felszabadító tulajdonságú peptidek, ezeket hatóanyagként tartalmazó gyógyszerkészítmények és alkalmazásuk
JP2001523232A (ja) ＧｎＲＨ拮抗物質
US5106834A (en) Linear free-sulfhydryl-containing oligopeptide derivatives as antihypertensive agents
JPH0219397A (ja) アルギニンバソプレシン拮抗剤の新規線形誘導体類
JPS63154699A (ja) バソプレシン拮抗剤
WO2018128828A1 (en) Novel hepcidin mimetics and uses thereof
JPS61191698A (ja) 新規な環状ヘキサペプチドｌｈｒｈ拮抗剤
SE501677C2 (sv) Biologiskt aktiva vasopressinanaloger, farmaceutiska preparat innehållande dem samt deras användning för framställning av läkemedel
CA2405704C (en) Bombesin analogs for treatment of cancer
AU676071B2 (en) Peptides exhibiting oxytocin antagonistic activity
KR0171614B1 (ko) 혈관활성 바소토신 유도체
EP1198478B1 (en) Somatostatin analogs and their use for the treatment of cancer
IE912378A1 (en) Derivatives of pituitary posterior lobe hormones
US6989371B1 (en) Bombesin analogs for treatment of cancer
JPS63303999A (ja) バソプレシン拮抗剤
WO2002000688A1 (fr) Compose peptidique, compositions pharmaceutiques et medicaments contenant ceux-ci comme principe actif

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19951123

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19980201